SPSIP Versus RISS Block in Volume-Preserving VATS

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorFerit Yetik

About this trial

This prospective randomized controlled study aims to compare the effects of Serratus Posterior Superior Intercostal Plane (SPSIP) block and Rhomboid Intercostal and Subserratus (RISS) block on postoperative pain, respiratory function, and recovery quality in patients undergoing volume-preserving video-assisted thoracoscopic surgery (VATS). Eighty-four patients will be randomized in a 1:1 ratio to receive either SPSIP block or RISS block. The primary outcome is the incidence of somatic pain at the chest drain insertion site at postoperative 2 hours. Secondary outcomes include pain scores, opioid consumption, quality of recovery, diaphragmatic function, pulmonary function, rescue analgesic requirements, postoperative nausea and vomiting, and block-related complications.

Eligibility criteria

Qualifiers

Patients scheduled for elective biportal video-assisted thoracoscopic surgery (VATS) with lung parenchyma-preserving thoracic procedures under general anesthesia

American Society of Anesthesiologists (ASA) physical status I-III

Age between 18 and 75 years

Provision of written informed consent

Disqualifiers

Use of anticoagulant or antiplatelet therapy

Bleeding diathesis

Known allergy to local anesthetics

Infection at the planned block site

Trial design

Treatments tested in this trial

  • Serratus posterior superior intercostal plane block
  • Rhomboid Intercostal and Subserratus Block

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ferit Yetik

Lead sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Sponsor institution

Bursa Sehir Hastanesi

Collaborator